Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 2

1(14.3%)

Phase 3

1(14.3%)

7Total

N/A(5)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03736707Not ApplicableRecruiting

High-Frequency Oscillation Ventilation Versus Conventional Mechanical Ventilation in Very Preterm Infants With Perinatal Acute Respiratory Distress Syndrome: Multicenters Randomized Controlled, Superiority Trial

Role: collaborator

NCT03591796Not ApplicableCompleted

Invasive Ventilation for Neonates With Acute Respiratory Distress Syndrome(ARDS)

Role: collaborator

NCT06890143Phase 3Recruiting

The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children

Role: collaborator

NCT05759754Not ApplicableCompleted

Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease

Role: collaborator

NCT04891666Not ApplicableCompleted

A Trial to Evaluate the Efficacy and Safety of Lactobacillus Plantarum DSM 33464 on Blood Lead Levels in Children

Role: collaborator

NCT04783675Phase 2Completed

Efficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic Syndrome

Role: collaborator

NCT03181958Not ApplicableCompleted

A Trial Comparing Noninvasive Ventilation Strategies in Preterm Infants Following Extubation

Role: collaborator

All 7 trials loaded